Aktueller Stand der Impfung gegen SARS-CoV-2

On 21 December 2020 the European Medicines Agency (EMA) approved the mRNA vaccine BNT162b2 (Comirnaty®, BioNTech, Mainz, Germany; Pfizer, New York City, NY, USA) as the first vaccine against SARS-CoV‑2 in the European Union and the second vaccine (Moderna®, Moderna, Cambridge, MA, USA) followed on 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Iking-Konert, Christof, Specker, Christof, Krüger, Klaus, Schulze-Koops, Hendrik, Aries, Peer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Hot Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852047/
https://www.ncbi.nlm.nih.gov/pubmed/33528655
http://dx.doi.org/10.1007/s00393-021-00966-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852047/
https://www.ncbi.nlm.nih.gov/pubmed/33528655
http://dx.doi.org/10.1007/s00393-021-00966-9

Ejemplares similares